Vireo Growth (VREOF) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Vireo Growth Inc.  (OTC: VREOF)
 

Vireo Growth Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Vireo Growth's Inventory turnover ratio has remained unchanged compare to previous quarter at 0.03 in the second quarter 2026Average processing period, for Vireo Growth's inventories remained unchanged at 12167 days, in the Jun 30 2026 quarter.

Within Healthcare sector Vireo Growth Inc. achieved the highest inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1929 in the first quarter 2026, to 1941.

VREOF Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Vireo Growth Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VREOF Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 137.02 % 226 % 176.79 % 171.6 % 213.71 %
Y / Y Cost of Sales Growth - -25 % 230.68 % 153.56 % -
Inventory Turnover Ratio (TTM) 0.03 0.03 0.04 0.03 -
VREOF's Total Ranking # 1941 # 1929 # # #
Average inventory processing period 12464 12423 9330 10490 -
Seq. Inventory Growth 96.32 % 26.9 % 11.26 % -14.49 % 170.03 %
Seq. Cost of Sales Growth 33.33 % -61.93 % -20.92 % - -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market # 1941

Inventory Turnover Ratio Statistics
High Average Low
1.85 0.32 -0.26
(Mar 31 2022)   (Mar 31 2023)



VREOF Company Profile >> Back to VREOF Efficiency Comparisons >> Compare VREOF Inventory Turnover Ratio to its Competitors

Financial Statements
Vireo Growth's Inventories $ 149 Millions Visit VREOF's Balance sheet
Vireo Growth's Cost of Revenues TTM $ 2 Millions Visit VREOF's Income Statement
What are VREOF's Sales? Visit VREOF's Sales by Segment

Other Inventory Turnover Ratios
Vireo Growth's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VREOF's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VREOF's Competitors
Inventory Turnover Ratio for VREOF's Suppliers
Inventory Turnover Ratio for VREOF's Customers

You may also want to know
VREOF's Sales Growth Rates VREOF's Pe Price to earnings ratio VREOF's Receivables Turnover Ratio VREOF's Stock Quote
VREOF's Net Income Growth Rates VREOF's Ps Price to Sales ratio VREOF's Sales per Employee VREOF's Asset Turnover Ratio
VREOF's Net Margin VREOF's Pb Price to Book ratio VREOF's Financial Strength Ratios VREOF's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Citius Oncology Inc  0.04 $ 0.821  Millions$ 21  Millions
Vireo Growth Inc.  0.03 $ 2.485  Millions$ 85  Millions

Date modified: 2026-08-17T17:19:27+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.